click below
click below
Normal Size Small Size show me how
Advanced Fluid Thera
WK 8
| Question | Answer |
|---|---|
| Fluid Therapy indications for use | Fluid deficit (fluid loss/shortage dehydration, hypovolaemia etc) Inability to keep up with fluid losses (diarrhoea, burns etc.). Maintenance fluids (including giving patient drink) Fluid therapy for the administration of medication and/or electrolytes |
| aims of fluid therapy | prevent too much or too little fluid administration ultimitley improve patient outcomes |
| ROSE | (Resuscitation, Optimisation, Stabilisation, Evacuation) |
| The 4 D’s | (Drug, Dosing, Duration, De-escalation) |
| fluid types | Prescription Only Medicine (Veterinary Surgeon) (POM-V) – excluding drinking water. Crystalloids. Colloids (natural and synthetic). Blood products. You must understand what is administered and the clinical signs to observe for |
| Fluid Types you must understand - | What a crystalloid is. What a colloid is. The difference between crystalloids and colloids. The different types of crystalloids and colloids. When crystalloids and colloids should be used (and not used!). |
| crystalloids - from table | smaller molecules and smaller molecular weight (electrolytes, glucose etc) have shorter intravascular retention time than colloids distribute widely throughout extracellular fluid, can easily move into extravascular space |
| crystalloids - | primary use is immediate fluid resuscitation, often rapid but temporary effect to increase vascular colume may be isotonicm hypotonic or hypertonic in composition cheap, easy to use and few side effects most common |
| colloids - from table | large molecules and larger molecular weight suspended in a crystalloid solution have longer intravascular retention time remain in the intravascular space for longer primary use is rapid volume expansion + maintenance with blood vessels |
| colloids - | greater and sustained increase in vascular volume may be synthetic, semi synthetic or natural in composition more expensive + increased risk of side effects infrequently used in veterinary practice |
| CRYSTALLOIDS | 0.9% normal saline solution. 0.45% sodium chloride (NaCl). Hartmann’s solution / Lactated Ringer’s solution. Dextrose (various solutions). + more! |
| saline solution = | a non-buffered crystalloid that may be used in cases of gastrointestinal fluid loss, metabolic alkalosis or hyperkalaemia. It is a mildly acidic solution. |
| Sodium chloride = | Nonbuffered crystalloids + mildly acidic solution may be used for hypovolaemic hyponatraemia (loss of total body water + sodium) with hypochloraemic metabolic alkalosis (high blood pH + low chloride ions). |
| Hartmann’s solution – | Balanced, buffered (lactate) isotonic crystalloid, close to blood composition (pH ~6.5). Used for fluid depletion from GI disease/shock. Avoid severe hyperK/Ca/Na/lactate, hyperhydration, metabolic alkalosis, oedema, Addison’s. Contains Ca, K, Na, lactate |
| Dextrose solution – | this type of fluid is often used in cases of hypoglycaemia to restore euglycaemia. There are different concentrations that can be used as prescribed by the Veterinary Surgeon. They are not often used as a replacement fluid. |
| COLLOIDS | Natural colloids: concentrated albumin solutions + some blood products. Synthetic/semi-synthetic colloids: gelatins, starches, dextrans + complex polysaccharides (Hetastarch, Pentastarch, Tetrastarch etc). Each suits different patient needs. |
| Some colloids are | blood products |
| Blood products and transfusions | Whole blood. Packed red blood cells. Platelet concentrate. Fresh frozen plasma. Frozen plasma or cryo-supernatant. Cryo-precipitate. |
| routes of administration | oral subcutaneous intravenous (most common) intraosseous |
| Oral Administration Advantages | Simple + can be done at home: offer a bowl of water and calculate/measure fluid intake to monitor requirements. Can help correct mild conditions such as mild salt toxicity or dehydration. Independent drinking is natural behaviour + should be encouraged |
| Oral Administration Disadvantages | Not suitable for GI disease (e.g. parvovirus), high fluid losses, reduced consciousness, inability to swallow, recumbency or NPO patients due to aspiration risk/inability to maintain hydration. IV or intraosseous fluids may be needed instead. |
| subcutaneous administration Advantages | Useful for mild dehydration or maintenance fluids when IV access is unnecessary/difficult. Less stressful than IV therapy and allows gradual fluid absorption, Simple, minimally invasive and inexpensive. |
| subcutaneous administration disadvantages | Slow absorption; unsuitable for shock, severe dehydration or large fluid deficits. Limited fluid volumes/rates. Risk of pain, infection, oedema or poor absorption. Avoid in hypothermia, poor perfusion, skin disease or severe electrolyte imbalance. |
| IV administration, veins used | cephalic, jugular and lateral saphenous veins in dogs; cephalic, jugular and medial saphenous/femoral veins in cats; and auricular veins in rabbits. |
| what if you cannot gain IV access using routine techniques in emergency situations | intravenous (peripheral) to intraosseous to intravenous (central) to venous cutdown (peripheral or central) |
| Intraosseous Administration | Into the medullary cavity of the bone consistent route of access to systemic circulation when hypotension and/or hemodynamic collapse is present. |
| Intraosseous Administration | Useful in neonates/paediatric patients or emergencies needing rapid circulation access. Absorption comparable to IV. Fluids, meds and lab samples possible. Max 72h in situ. Sites: proximal humerus/tibia, humeral condyle, femur, ilium. |
| intraosseous Administration | Placement via an intraosseous needle, spinal needle, hypodermic needle or bone narrow aspirate needle. |
| Intraosseous Administration Contraindications | Osteomyelitis. Regional pyoderma. Pre-existing fracture. Orthopaedic implants in the location of interest |
| Intraosseous Administration Complications | Dislodgement and leakage. Infection (osteomyelitis, subcutaneous abscess). Excessive pain. Epiphyseal injury in neonates/paediatrics. Bone fracture. Localised haemorrhage. Nerve damage (sciatic nerve if using trochanteric fossa of femur). |
| Central Venous Access Central catheters = | jugular vein, then fed into central circulation via cranial vena cava. Peripherally inserted central catheters (PICCs) to cephalic, saphenous or femoral vein, then fed into central circulation (via cranial or caudal vena cava). |
| Central Venous Access | INDEPENDANT STUDY !!!!!! |
| Venous Cutdown | Often last resort ! Time consuming. Increased nosocomial infection risk. High placement success rate in canine cadavers RVNs can perform under Schedule 3 If conducted in the conscious patient, a local anaesthetic should be administered |
| Assessment and Care of the Patient Full physical examination of the patient to include: | Urine specific gravity: dogs 1.015-1.045, cats 1.035-1.060. PCV: dogs 37-55%, cats 24-45%. TS 60-75g/L. Bodyweight, BP (SAP/DAP/MAP), demeanour, vital signs, RR/effort/noise assessed before+during fluid therapy to monitor response |
| Assessment and Care of the Patient Hypovolaemia (loss of intravascular fluid) | Tachycardia. Weak distal pulses. Prolonged capillary refill time. Pale mucous membranes. Cold extremities (+/- hypothermia). Hypotension. Oliguria. |
| Assessment and Care of the Patient Dehydration (global loss of water) | Dry mucous membranes. Skin tenting. Sunken eyes. Dry cornea. Doughy abdomen. Increased thirst. Minimum detection level at physical examination = 5%. |
| Assessment and Care of the Patient Need to consider ‘other/hidden’ fluids being administered. What other fluids? | Intravenous flush fluids. Liquid medications. Constant rate infusions. Nutrition (food and water). |
| Assessment and Care of the Patient Monitor for fluid overload as not all patients respond in the same way Who is at higher risk? | Renal disease/failure patients. Neonates and paediatrics. Patients also receiving ‘other/hidden’ fluids. Patients who are inadequately monitored whilst receiving fluid therapy. Patients receiving aggressive fluid therapy |